Litcius/Paper detail

Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial

Robert D. Morgan, Iain A. McNeish, Adrian Cook, Elizabeth C James, Rosemary Lord, G. Dark, Rosalind Glasspool, Jonathan Krell, Christine Parkinson, Christopher Poole, Marcia Hall, Dolores Gallardo‐Rincón, Michelle Lockley, Sharadah Essapen, Jeff Summers, Anjana Anand, Abel Zachariah, Sarah Williams, Rachel Jones, Kate Scatchard, Axel Walther, Jae‐Weon Kim, Sudha Sundar, Gordon C. Jayson, Jonathan A. Ledermann, Andrew R. Clamp

2020The Lancet Oncology63 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCarboplatinGynecologic oncologyFallopian tube cancerSerous carcinomaFallopian tubeOvarian cancerOncologyResponse Evaluation Criteria in Solid TumorsInternal medicineChemotherapyCancerGynecologyCisplatinPhases of clinical researchOvarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometrial and Cervical Cancer Treatments